Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Cancer's persistent growth often relies on its ability to maintain telomere length and tolerate the accumulation of DNA damage. This study explores a computational approach to identify compounds that can simultaneously target both G-quadruplex (G4) structures and poly(ADP-ribose) polymerase (PARP)1 enzyme, offering a potential multipronged attack on cancer cells. We employed a hybrid virtual screening (VS) protocol, combining the power of machine learning with traditional structure-based methods. PyRMD, our AI-powered tool, was first used to analyze vast chemical libraries and to identify potential PARP1 inhibitors based on known bioactivity data. Subsequently, a structure-based VS approach selected compounds from these identified inhibitors for their G4 stabilization potential. This two-step process yielded 50 promising candidates, which were then experimentally validated for their ability to inhibit PARP1 and stabilize G4 structures. Ultimately, four lead compounds emerged as promising candidates with the desired dual activity and demonstrated antiproliferative effects against specific cancer cell lines. This study highlights the potential of combining Artificial Intelligence and structure-based methods for the discovery of multitarget anticancer compounds, offering a valuable approach for future drug development efforts.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/acs.jcim.4c01132 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Predicting nucleic acid binding sites by attention map-guided graph convolutional network with protein language embeddings and physicochemical information.
Brief Bioinform
August 2025
School of Information and Artificial Intelligence, Anhui Agricultural University, 130 Changjiang Road, Shushan District, Hefei, Anhui 230036, China.
Protein-nucleic acid binding sites play a crucial role in biological processes such as gene expression, signal transduction, replication, and transcription. In recent years, with the development of artificial intelligence, protein language models, graph neural networks, and transformer architectures have been adopted to develop both structure-based and sequence-based predictive models. Structure-based methods benefit from the spatial relationship between residues and have shown promising performance.
View Article and Find Full Text PDFRole of voltage-dependent anion channel 1 in neurodegeneration: Mechanisms, implications, and therapeutic potential.
Neural Regen Res
September 2025
Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Voltage-dependent anion channel 1 is an integral outer membrane protein of the mitochondria that governs apoptosis, enables metabolite exchange, and influences mitochondrial activity. In neurodegenerative diseases, such as amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease, and Alzheimer's disease, oxidative stress, neuroinflammation, and mitochondrial dysfunction are frequent features. Voltage-dependent anion channel 1 is a key regulator of these processes.
View Article and Find Full Text PDFPredicting radiation pneumonitis in lung cancer patients using robust 4DCT-ventilation and perfusion imaging.
Radiother Oncol
September 2025
Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, United States. Electronic address:
Purpose: Methods have been developed that apply image processing to 4-Dimension computed tomography (4DCT) to generate lung ventilation (4DCT-ventilation). Traditional methods for 4DCT-ventilation rely on density-change methods and lack reproducibility and do not provide 4DCT-perfusion data. Novel 4DCT-ventilation/perfusion methods have been developed that are robust and provide 4DCT-perfusion information.
View Article and Find Full Text PDFDecoding the limits of deep learning in molecular docking for drug discovery.
Chem Sci
August 2025
Xiangya School of Pharmaceutical Sciences, Central South University Changsha 410013 Hunan P.R. China
Structure-based molecular docking, a cornerstone of computational drug design, is undergoing a paradigm shift fueled by deep learning (DL) innovations. However, the rapid proliferation of DL-driven docking methods has created uncharted challenges in translating predictions to biomedical reality. Here, we delve into the performance and prospects of traditional methods and state-of-the-art DL docking paradigms-encompassing generative diffusion models, regression-based architectures, and hybrid frameworks-across five critical dimensions: pose prediction accuracy, physical plausibility, interaction recovery, virtual screening (VS) efficacy, and generalization across diverse protein-ligand landscapes.
View Article and Find Full Text PDFBeyond rigid docking: deep learning approaches for fully flexible protein-ligand interactions.
Brief Bioinform
August 2025
Bioinformatics Center, Institute for Chemical Research, Kyoto University, Uji 611-0011, Japan.
Sparked by AlphaFold2's groundbreaking success in protein structure prediction, recent years have seen a surge of interest in developing deep learning (DL) models for molecular docking. Molecular docking is a computational approach for predicting how proteins interact with small molecules known as ligands. It has become an essential tool in drug discovery, enabling structure-based virtual screening (VS) methods to efficiently explore vast libraries of drug-like molecules and identify potential therapeutic candidates.
View Article and Find Full Text PDF